Elevated pim-1 and c-myc proto-oncogene induction in B lymphocytes from BLV-infected cows with persistent B lymphocytosis

Leukemia

Volumn 10, Issue 10, 1996, Pages 1629-1638

  Stone, D M ^a   Norton, L K ^a   Magnuson, N S ^a   Davis, W C ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

BLV; c myc; Lymphocytosis; mRNA; Oncogenes; pim 1

Indexed keywords

CD5 ANTIGEN; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BOVINE LEUKEMIA VIRUS; CATTLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE INDUCTION; LYMPHOCYTOSIS; MONOCYTE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTO ONCOGENE; VIRUS INFECTION;

EID: 0029785635     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Sagata N, Yasanuga T, Tsuzuku-Kawamura J, Ohihi K, Ogawa Y, Ihawa I. Complete nucleotide sequence of the genome of bovine leukemia virus: its evolutionary relationship to other retroviruses. Proc Natl Acad Sci USA 1985; 82: 677-682.
2. Depelchin A, Letesson JJ, Lostrie-Trussart N, Mammerickx M, Portetelle D, Burny A. Bovine leukemia virus (BLV)-infected B-cells express a marker similar to the CDS T cell marker. Immunol Lett 1989; 20: 69-76.
3. Mirsky ML, Da Y, Lewin HA. Detection of bovine leukemia virus proviral DNA in individual cells. PCR Methods and Applications 1993; 2: 333-339.
4. Burny A, Bruck C, Cleuter Y, Couez D, Deschamps J, Ghysdael J, Bregoire D, Kettmann R, Mammerickx M, Marbaix G, Portelle D. Bovine leukemia virus: a new mode of leukemogenesis. In: Klein G (ed). Bovine Leukemia Virus. Raven Press: New York, 1985, pp 35-55.
5. Jensen WA, Rovnak J, Cockerell GL. In vivo transcription of the bovine leukemia virus tax/rex region in normal and neoplastic lymphocytes of cattle and sheep. J Virol 1991; 65: 2484-2490.
6. Stone DM, McElwain TF, Davis WC. Enhanced B-lymphocyte expression of IL-2Rα associated with T lymphocytosis in BLV-infected persistently lymphocytotic cows. Leukemia 1994; 8: 1057-1061.
7. Stone DM, Hof AJ, Davis WC. Up-regulation of IL-2 receptor α and MHC class II antigen expression on lymphocyte subpopulations from bovine leukemia virus infected lymphocytotic cows. Vet Immunol Immunopathol 1995; 48: 65-76.
8. Cooper GM. Oncogenes in mitogenic signal transduction pathways. In Oncogenes. Jones and Bartlett: Boston, 1990, pp 1-323.
9. Penn LJZ, Laufer EM, Land H. C-MYC: evidence for multiple regulatory functions. Semin Cancer Biol 1990; 1: 69-87.
10. Hunter T. Cooperation between oncogenes. Cell 1991; 64: 249-270.
11. Amson R, Sigaux F, Przedborski S, Flandrin G, Bivol D, Telerman A. The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. Proc Natl Acad Sci USA 1989; 86: 8857-8861.
12. Bishop JM. Cellular oncogenes and retroviruses. Ann Rev Biochem 1983; 52: 301-354.
13. van Lohuizen M, Verbeek S, Krimpenfort P, Domen J, Saris C, Radaszkiewicz T, Berns A. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell 1989; 56: 673-682.
14. Breuer M, Vientjens E, Verbeek S, Slebos R, Berns A. Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras. Cancer Res 1991; 51: 958-963.
15. Verbeek A, van Lohuizen M, van der Valk M, Domen J, Kraal G, Berns A. Mice bearing the Ep-myc and Eμ-pim-1 transgenes develop pre-B cell leukemia prenatally. Mol Cell Biol 1990, 11: 1176-1179.
16. Moray E, Verbeek S, Ma A, Achacoso P, Berns A, Alt F. Eμ N-and Eμ L-myc cooperate with Eμ pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice. Oncogene 1991; 6: 1941-1948.
17. van Lohuizen M, Verbeek S, Scheijen B, Wientjens E, van der Gulden H, Berns A. Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging. Cell 1991; 65: 737-752.
18. Meeker TC, Nagarajan L, Ar-Rushdi A, Rovera G, Huebner K, Croce CM. Characterization of the human PIM-1 gene: a putative proto-oncogene coding for a tissue specific member of the protein kinase family. Oncogene Res 1987; 1: 87-101.
19. Sorrentino A, McKinney MD, Giorgi M, Geremia R, Fleissner R. Expression of cellular protooncogenes in the mouse male germ line: a distinctive 2.4-kilobase pim-1 transcript is expressed in haploid postmeiotic cells. Proc Natl Acad Sci USA 1988; 85: 2191-2195.
20. Wingett D, Reeves R, Magnuson NS. Characterization of the testes-specific pim-1 transcript in rat. Nucleic Acids Res 1992; 20: 3183-3188.
21. Moray R, Grzeschiczek A, Petzold S, Hartman KU. Expression of a pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in Ipr/lpr mice. Proc Natl Acad Sci USA 1993; 90: 10734-10738.
22. Meuer SD, Hussey RE, Cantrell DA, Hodgdon JC, Schlossman SF, Smith KA, Reinherz EL. Triggering of the T3-Ti antigen receptor complex results in clonal T cell proliferation through an interleukin 2 dependent autocrine pathway. Proc Natl Acad Sci USA 1984; 81: 1509-1512.
23. Reed JD, Sabath DE, Hoover RG, Prystowsky MB. Recombinant interleukin 2 regulates levels of c-myc mRNA in a cloned murine T lymphocyte. Mol Cell Biol 1985; 5: 3361-3368.
24. Dautry F, Weil D, Yu J, Dautry-Varsat A. Regulation of pim and myb mRNA accumulation by interleukin 2 and interleukin 3 in murine hematopoietic cell lines. J Biol Chem 1988; 263: 17615-17620.
25. Semenzato G, Pizzolo G, Zambello R. The interleukin-2/interleukin-2 receptor system: structural, immunological, and clinical features. Int J Clin Lab Res 1992; 22: 133-142.
26. Yodoi J, Uchiyama T. Review. Diseases associated with HTLV-1: virus, IL-2 receptor dysregulation and redox regulation. Immunol Today 1992; 13: 405-411.
27. Collins RA, Oldham G. Recombinant human interleukin 2 induces proliferation and immunoglobulin secretion by bovine B-cells: tissue differences and preferential enhancement of immunoglobulin A. Vet Immunol Immunopathol 1993; 36: 31-43.
28. + subset contained within the germinal center cell-enriched (surface IgD-/CD39- buoyant) fraction of human tonsil. Int Immunol 1993; 5: 1059-1066.
29. Mitsui H, Yagura H, Tamaki T, Ideka H, Matsumura I, Kanakura Y, Yonezawa T, Tarui S. High-affinity interleukin 2 receptors on B cell chronic lymphocytic leukemia cells are induced by phorbol myristate acetate but not by calcium ionophore. Immunol Lett 1991; 27: 105-112.
30. Holan V, Minowada J. Interleukin-2 production by human leukemia cell lines of pre-B cell origin. Neoplasia 1993; 40: 3-8.
31. Bendixen HJ. Bovine enzootic leukosis. Adv Vet Sci 1965; 10: 129-203.
32. Henry C. Cell separation: nylon wool. In: Mishell BB, Shiigi SM (eds). Selected Methods in Cellular Immunology. WH Freeman and Co: San Francisco, 1980, pp 182-185.
33. Davis WC, Hamilton MJ, Park Y, Larsen RA, Wyatt CR, Okada K. Ruminant leukocyte differentiation molecules. In: Barta O (ed). MHC Differentiation Antigens, and Cytokines in Animals and Birds. Monographs in Animal Immunology. BAR-Lab: Blacksburg, 1990, pp 47-78.
34. Davis WC, MacHugh ND, Park Y, Hamilton MJ, Wyatt CR. Identification of a monoclonal antibody reactive with the bovine orthologue of CD3 (BoCD3). Vet Immunol Immunopathol 1993; 39: 85-91.
35. Davis WC, Larsen RA, Lonaghan ML. Genetic markers identified by immunogenetic methods. American Fisheries Society Symposium 1990; 7: 521-540.
36. Ausubel FM (ed). Current Protocols in Molecular Biology, Vols 1 and 2. John Wiley and Sons: New York, 1990.
37. Wingett D, Reeves R, Magnuson NS. Stability changes in pim-1 proto-oncogene mRNA mitogen stimulation of normal lymphocytes. J Immunol 1991; 147: 3653-3659.
38. Reeves R, Spies GA, Kiefer M, Barr PU, Power M. Primary structure of the putative human oncogene, pim-1. Gene 1990; 90: 330-307.
39. Land H, Pwada LF, Weiberg RA. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperation oncogenes. Nature 1983; 304: 596-602.
40. Berns A, Cuypers HT, Selton G, Domen J. Pim-1 activation in T-cell lymphomas. In: Kjeldgaard NO, Forchhamer J (eds). Viral Carcinogenesis, Alfred Benzon Symposium 24, Monksgaard, Copenhagen, 1987, p 211.
41. Eisenman RN. Nuclear oncogenes. Oncogenes and the Molecular Origins of Cancer. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1989, pp 179-182.
42. Wingett D, Stone D, Davis WC, Magnuson NS. Expression of the pim-1 proto-oncogene: differential inducibility between α/β- and γ/δ T cells and B cells. Cell Immunol 1995; 162: 123-130.
43. Gupta P, Kashmiri SVS, Erisman MD, Rothberg PG, Astrin SM, Ferrer JF. Enhanced expression of the c-myc gene in bovine leukemia virus-induced bovine tumors. Cancer Res 1986; 46: 6295-6298.
44. Reeves R, Spies GA, Nissen MS, Buck CD, Weinberg AD, Barr PJ, Magnuson NS, Magnuson JA. Molecular cloning of a functional bovine interleukin 2 cDNA. Proc Natl Acad Sci USA 1986; 83: 3228-3232.
45. Weinberg AD, Magnuson NS, Reeves R, Wyatt CR, Magnuson JA. Evidence for two discrete phases of IL-2 production in bovine lymphocytes. J Immunol 1988; 141: 1174-1179.
46. Garlisi CG, Mastro AM. Production of interleukin-2 mRNA by bovine lymph node lymphocytes in response to concanavalin A, 12-O-tetradecanoylphobol-13-acetate, and ionomycin. Vet Immunol Immunopathol 1992; 30: 359-372.
47. - B cell subsets to T cell-independent mitogens. Eur J Immunol 1991; 21: 351-359.
48. - anti-DNA antibody-producing B cells in murine lupus. Autoimmunity 1993; 14: 205-214.
49. Levy D, Deshayes L. Bovine leukemia virus specific antibodies among French cattle. Radioimmunoassay with the major structural protein (BLV p24). Int J Cancer 1977; 20: 543-550.
50. + B-cell expansion with lymphomagenesis in BLV infected sheep. Leukemia 1994; 8: 1890-1899.